Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancer|August 1, 2007
Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?Stephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Urologic Clinics of North America|May 9, 2007
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcomeStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|April 18, 2009
Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgeryStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissectionStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|June 15, 2007
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patientsStephen D W Beck, Matthew D Peterson, Richard Bihrle, et al.
The Journal of Urology|May 29, 2003
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?Ashraf A Mosharafa, Richard S Foster, Bradley C Leibovich, et al.
The Journal of Urology|June 11, 2005
Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumorStephen D W Beck, Richard S Foster, Richard Bihrle, et al.
The Journal of Urology|March 23, 2013
Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissectionPaul Johnston, Stephen D W Beck, Liang Cheng, et al.
Pageof 7